Interlink Electronics, Inc. — FY2017 Form 10-K
Reporting period: Fiscal year ended December 31, 2017, compared with FY2016. Although the request identifies 2017 Q4, this filing reports annual results; it does not provide clear standalone fourth-quarter financial results. The company designs, manufactures and sells force-sensing and human-machine-interface (HMI) components and custom solutions for consumer electronics, automotive, industrial and medical markets.
Financial performance and position
| Metric | FY2017 | FY2016 |
|---|---|---|
| Net revenue | $11.153 million | $11.886 million |
| Gross profit / margin | $6.856 million / 61.5% | $7.006 million / 58.9% |
| Operating income / margin | $2.139 million / 19.2% | $2.847 million / 24.0% |
| Net income | $1.260 million | $2.893 million |
| Diluted EPS | $0.17 | $0.39 |
| Operating cash flow | $2.046 million | $1.886 million |
| Investing cash flow | ($0.429 million) | ($0.230 million) |
At year-end, cash and cash equivalents were $7.772 million, working capital was $10.0 million, total current assets were $10.684 million and total liabilities were $0.703 million. The company reported no indebtedness. Cash increased $1.763 million during the year, including a favorable $112,000 foreign-currency translation effect on cash. Capital spending supported the Singapore R&D expansion. Operating lease commitments totaled $599,000 through 2021.
Material changes versus FY2016
- Revenue fell 6.2%, primarily after an automotive customer redesigned a product and no longer needed Interlink’s solution. Automotive revenue declined 45.9% to $1.986 million.
- Industrial revenue increased 27.2% to $2.045 million; medical increased 17.2% to $1.640 million; consumer increased 42.3% to $1.906 million. Standard-product revenue fell 7.6% to $3.576 million.
- Gross margin improved to 61.5% from 58.9%, which management attributed mainly to manufacturing efficiencies, better fixed-cost utilization and lower production overhead.
- Operating expenses rose 13.4% to $4.717 million, including higher R&D spending for the Singapore center and increased sales and marketing resources. Operating income declined 24.9%.
- Net income decreased substantially, in part because FY2017 included $874,000 of tax expense, versus a $6,000 tax benefit in FY2016. FY2017 tax expense included a $169,000 charge to remeasure deferred taxes following U.S. tax reform. FY2016 included a $989,000 benefit from releasing a valuation allowance.
- International sales were 51.8% of revenue, up from 42.5%. Three customers represented approximately 17%, 15% and 14% of FY2017 revenue.
Outlook, risks and other notable items
- Management expected revenue to be relatively flat in the first half of 2018 while replacing lost automotive revenue. It noted that new medical-program revenue was beginning to materialize, but expected end-of-life products to offset some growth early in 2018. Management expressed confidence in demand and its HMI position, but provided no quantified full-year guidance.
- Interlink planned to expand its Singapore R&D operation over three years, including adding 10 scientists and engineers and investing $3.5 million in a state-of-the-art facility. Acquisition opportunities would continue to be evaluated; their effects were not included in the outlook.
- Management expected a significantly lower effective tax rate in future periods following the reduction in the U.S. federal corporate rate, while noting that the Tax Cuts and Jobs Act’s effects remained subject to further analysis.
- Key risks include customer and product concentration, long and uncertain design cycles, price competition, dependence on customer product success and cancellable purchase orders, reliance on suppliers (including single-source components), and manufacturing concentration in China. International operations also expose the company to currency, trade, regulatory and geopolitical risks.
- Other risks include technology and market-acceptance uncertainty, intellectual-property protection and infringement claims, cyberattacks, retention of key personnel, and limits on use of tax-loss carryforwards. The CEO beneficially owned 71.2% of common stock and also held leadership roles at other companies; the CFO also served another public company.
- The company reported no pending legal proceedings and no material warranty returns historically. It had a $1 million share-repurchase authorization approved in December 2017; after year-end, it repurchased 34,010 shares for $4.75 per share. Management reported effective disclosure controls and internal control over financial reporting; the auditor did not provide an internal-control attestation.
Important facts for investors to verify
- Whether replacement programs and newer medical, industrial and consumer designs offset the automotive design loss, and how customer design cycles affect revenue timing.
- Customer concentration and exposure to order changes, product discontinuations and a small number of significant accounts.
- Progress, timing and funding of the planned Singapore R&D expansion, including the stated $3.5 million investment and hiring plan.
- The realized effects of the 2017 U.S. tax law, including the future effective tax rate and any subsequent adjustments to tax estimates.
- Cash deployment, including acquisitions and share repurchases, and whether liquidity remains adequate if operating performance falls short of expectations.
- Foreign cash, supplier and manufacturing exposures, and the status of risks tied to China operations and international trade.